Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Cresci

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Diabetes|May 26, 2019
A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D StudiesYaling Tang, Petra A Lenzini, Rodica Pop-Busui, et al.
BMC Medical Genetics|October 1, 2011
Investigation of 95 variants identified in a genome-wide study for association with mortality after acute coronary syndromeThomas M Morgan, John A House, Sharon Cresci, et al.
Journal of the American College of Cardiology|April 10, 2024
Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic CardiomyopathyMartin S Maron, Masliza Mahmod, Azlan Helmy Abd Samat, et al.
Diabetes|January 25, 2020
<i>PPARA</i> Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-LipidMario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, et al.
Frontiers in Physiology|July 11, 2022
Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-AnalysisTessa Schillemans, Vinicius Tragante, Buamina Maitusong, et al.
European Heart Journal|March 22, 2021
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortalityStefan J Schunk, Marcus E Kleber, Winfried März, et al.
The New England Journal of Medicine|November 13, 2014
Inactivating mutations in NPC1L1 and protection from coronary heart disease, Nathan O Stitziel, Hong-Hee Won, et al.
Circulation|July 14, 2020
Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant DataBakhtawar K Mahmoodi, Vinicius Tragante, Marcus E Kleber, et al.
Nature|December 10, 2014
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarctionRon Do, Nathan O Stitziel, Hong-Hee Won, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2017
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association studyStephen Zewinger, Marcus E Kleber, Vinicius Tragante, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Diabetes|May 26, 2019
A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D StudiesYaling Tang, Petra A Lenzini, Rodica Pop-Busui, et al.
BMC Medical Genetics|October 1, 2011
Investigation of 95 variants identified in a genome-wide study for association with mortality after acute coronary syndromeThomas M Morgan, John A House, Sharon Cresci, et al.
Journal of the American College of Cardiology|April 10, 2024
Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic CardiomyopathyMartin S Maron, Masliza Mahmod, Azlan Helmy Abd Samat, et al.
Diabetes|January 25, 2020
<i>PPARA</i> Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-LipidMario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, et al.
Frontiers in Physiology|July 11, 2022
Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-AnalysisTessa Schillemans, Vinicius Tragante, Buamina Maitusong, et al.
European Heart Journal|March 22, 2021
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortalityStefan J Schunk, Marcus E Kleber, Winfried März, et al.
The New England Journal of Medicine|November 13, 2014
Inactivating mutations in NPC1L1 and protection from coronary heart disease, Nathan O Stitziel, Hong-Hee Won, et al.
Circulation|July 14, 2020
Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant DataBakhtawar K Mahmoodi, Vinicius Tragante, Marcus E Kleber, et al.
Nature|December 10, 2014
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarctionRon Do, Nathan O Stitziel, Hong-Hee Won, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2017
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association studyStephen Zewinger, Marcus E Kleber, Vinicius Tragante, et al.
Pageof 8